The Enterprise Value as of December 2025 (TTM) for China Resources Pharmaceutical Group Limited (3320.HK) is 101.50B

According to China Resources Pharmaceutical Group Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 101.50B. This represents a change of 9.84% compared to the average of 92.41B of the last 4 quarters.

China Resources Pharmaceutical Group Limited (3320.HK) Historical Enterprise Value (quarterly & annually)

How has 3320.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of China Resources Pharmaceutical Group Limited over the last ten years is 82.06B. The current 101.50B Enterprise Value has changed 12.27% with respect to the historical average. Over the past ten years (40 quarters), 3320.HK's Enterprise Value was at its highest in in the June 2019 quarter at 113.12B. The Enterprise Value was at its lowest in in the January 2013 quarter at 0.

China Resources Pharmaceutical Group Limited (3320.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of China Resources Pharmaceutical Group Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

China Resources Pharmaceutical Group Limited (3320.HK) Average Enterprise Value

How has 3320.HK Enterprise Value performed in the past?

The current Enterprise Value of China Resources Pharmaceutical Group Limited (3320.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

China Resources Pharmaceutical Group Limited (3320.HK) Enterprise Value vs. Peers

How is 3320.HK’s Enterprise Value compared to its peers?

China Resources Pharmaceutical Group Limited’s Enterprise Value is greater than Grand Pharmaceutical Group Limited (32.71B), greater than Livzon Pharmaceutical Group Inc. (26.54B), greater than China Medical System Holdings Limited (26.85B), greater than The United Laboratories International Holdings Limited (19.25B), less than Xuanzhubio-b (0), greater than Asymchem Laboratories (Tianjin) Co., Ltd. (24.38B), greater than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (49.26B), greater than Simcere Pharmaceutical Group Limited (28.67B), greater than HUTCHMED (China) Limited (1.16B), greater than Shandong Weigao Group Medical Polymer Company Limited (19.01B),

Build a custom stock screener for China Resources Pharmaceutical Group Limited (3320.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Resources Pharmaceutical Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China Resources Pharmaceutical Group Limited (3320.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China Resources Pharmaceutical Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.